PRKAA1 and neoplasm: Evidence that AMPK can promote tumours was also obtained recently using a mouse model of lung cancer in which the tumours develop in situ at their site of origin, and in which the authors had ‘bitten the bullet’ by knocking out both AMPK-α1 and -α2.